Microsoft and Imprivata collaborate on cloud based healthcare platform

Medcity | May 05, 2019

The tech giant and the health IT security company have teamed up to develop an identity and access management cloud platform for the healthcare industry. Microsoft and health IT security company Imprivata have teamed up to create an identity and access management (IAM) cloud platform for the healthcare industry.

Spotlight

This memorandum summarizes the Office of the Actuary’s estimates of the financial and coverage effects through 2026 of selected provisions of the “American Health Care Act of 2017” (H.R. 1628), which was passed by the House on May 4, 2017 and which is referred to in this memorandum as the AHCA. Included are the estimated impacts on net Federal expenditures, health insurance coverage, Medicaid enrollment and spending by eligibility group, gross and net premiums and out-of-pocket costs in the individual market, total National Health Expenditures, and the financial status of the Medicare Hospital Insurance (HI) trust fund.

Spotlight

This memorandum summarizes the Office of the Actuary’s estimates of the financial and coverage effects through 2026 of selected provisions of the “American Health Care Act of 2017” (H.R. 1628), which was passed by the House on May 4, 2017 and which is referred to in this memorandum as the AHCA. Included are the estimated impacts on net Federal expenditures, health insurance coverage, Medicaid enrollment and spending by eligibility group, gross and net premiums and out-of-pocket costs in the individual market, total National Health Expenditures, and the financial status of the Medicare Hospital Insurance (HI) trust fund.

Related News

HEALTH TECHNOLOGY

Trukera™ Medical Launches New ScoutPro™ Osmolarity System

Trukera Medical | September 13, 2022

Trukera™ Medical last week announced a corporate rebranding to reflect thea company’s expanded vision and strategic growth plans targeting broader unmet needs in corneal health. Trukera Medical unveiled the first product under the new company name, the ScoutPro™ Osmolarity System. Designed to help advance corneal health decisions for today’s busy eye care practices, ScoutPro is the first and only portable osmometer in the U.S. “The ScoutPro Osmolarity System is an exciting technology developed around the evolving needs of today’s eye care professionals. Premium cataract and refractive practices are now the fastest growing adopters of osmolarity testing, given the prevalence of hyperosmolarity in their patient demographics and the risk it poses to compromising corneal cell health and driving refractive instability. More than ever, these practices require patient care solutions that can seamlessly adapt into established operational models, not the other way around, to deliver a premium patient experience, efficiency of care, and minimize staff time and disruptions. We’re proud to bring a solution to market addressing these needs, and to help more practices objectively identify and manage such a critical component to patient’s corneal health and refractive outcomes.” Adam Szaronos, Trukera Medical CEO The ScoutPro Osmolarity System brings together nanoliter volume sample collection and analysis in a single portable device. Users can now bring laboratory testing to patients anywhere in the practice to quickly test and provide objective results in the palm of their hand. The system is built upon the company’s established accuracy trusted in over 24 million tests globally to date, with an industry-leading precision. “Toxic hyperosmolarity damages sensitive corneal nerves and may cause refractive instability. As cornea and cataract/refractive specialists, we are cognizant of the importance of this to our surgical outcomes and the overall health of our patients’ eyes. ScoutPro gives us the ability to precisely determine osmolarity quickly and easily, without disrupting patient flow,” said Dr. Lisa Nijm, Chief Medical Advisor for Ophthalmology at Trukera Medical and Corneal Surgeon at Warrenville Eye Care and LASIK Center in Illinois. The ScoutPro Osmolarity System is now available for pre-order in the U.S. and will be commercially launched at the upcoming World Cornea Congress and the American Academy of Ophthalmology later this month. About Trukera Medical Trukera Medical is a global leader in developing and marketing comprehensive corneal health technologies. The company introduced tear osmolarity testing to eye care with its flagship device, the TearLab Osmolarity System, which has been used over 24 million times worldwide. Trukera Medical’s expanding portfolio includes ScoutPro, the first and only portable osmolarity system in the U.S. The company’s dedicated focus is improving corneal health, both as a primary goal and in preparation for surgery.

Read More

HEALTH TECHNOLOGY

Allegheny Health Network Launches Unique Mobile Internal Staffing Model to Improve Recruitment, Retention of Nurses

Allegheny Health Network | August 20, 2022

As part of its ongoing efforts to better recruit and retain talented health professionals amid the significant labor shortages impacting the healthcare industry, Allegheny Health Network (AHN) announced today the launch of a new mobile internal staffing model that will provide flexible work life solutions for nurses, surgical technologists, and other team members. Called "Work Your Way," the new AHN program is seeking qualified internal and external applicants to work rotational shifts in telemetry, critical care, perioperative care and emergency medicine at the following AHN hospitals: Allegheny General, West Penn, Forbes, Jefferson, Wexford, Canonsburg, Allegheny Valley and Saint Vincent. The positions offer premium pay as well as mileage reimbursement for those traveling more than 50 miles to work and lodging reimbursement for those traveling more than 75 miles to work. "The severe nursing shortage across the nation continues to affect all hospitals and health systems. Creating and executing innovative solutions helps us address the staffing challenge and at AHN we are doing just that. Our new mobile internal staffing program is one of many solutions relative to the staffing challenges. It's also an opportunity for nurses who are interested in joining AHN's community of nursing in a unique way with competitive wages, excellent benefits, and the flexibility of practice at different AHN hospitals. AHN Chief Nurse Executive Claire Zangerle, DNP, RN, FAAN "Interest in this program is high, and several nurses have already signed on as members of the internal staffing team," Zangerle said. "We are confident this model will greatly reduce our reliance on contracted agency nurses and provide our employees with a unique work option that suits their individual needs and preferences." Zangerle said nurses at AHN are empowered to practice at their highest level in all settings, putting the patient at the center of their work by embracing evidence-based practices and collaborating across clinical disciplines. "The "Work Your Way" nurse lifestyle program at AHN provides nurses with the freedom and flexibility they told us they wanted – choosing how they want to work, with various options to the mobile internal staffing team, including a 'weekend warrior' program for those who prefer to work weekends and a 'night owl' program for those who prefer to work the night shifts," Zangerle said. About the Allegheny Health Network Allegheny Health Network (AHN.org) is an integrated healthcare delivery system serving the greater Western Pennsylvania region. The Network is composed of 14 hospitals, ambulatory surgery centers, Health + Wellness Pavilions, an employed physician organization, home and community-based health services, a research institute, and a group purchasing organization. The Network provides patients with access to a complete spectrum of advanced medical services, including nationally recognized programs for primary and emergency care, trauma care, cardiovascular disease, organ transplantation, cancer care, orthopedic surgery, neurology and neurosurgery, women's health, diabetes, autoimmune disease and more. AHN employs approximately 21,000 people, has more than 2,600 physicians on its medical staff and serves as a clinical campus for Drexel University College of Medicine and the Lake Erie College of Osteopathic Medicine.

Read More

HEALTH TECHNOLOGY

nference Launches AI-Driven Platform and Expands Partnership with Mayo Clinic, Offering Access to One of the Deepest Real-World

nference | September 22, 2022

nference, a science-first software company transforming healthcare by making biomedical data computable announced the launch of its AI-driven nSights platform, which will allow biopharma, medical device companies, and diagnostic firms to access and directly engage with curated, de-identified healthcare data to advance research and discovery. The company also expanded its exclusive 12-year strategic relationship with Mayo Clinic, providing nference partners and customers with access to Mayo Clinic Platform’s extensive de-identified electronic health data across a range of disease and therapeutic areas. This expanded collaboration will increase access to data-derived insights and knowledge by establishing a Mayo Clinic-branded version of nSights, called Mayo Clinic Platform_Discover, built and supported by nference to help its partners solve some of the most complex clinical challenges. nSights is a software platform that makes real-world data available across multiple data modalities (clinical, molecular, and imaging). The platform enables data exploration, hypothesis generation, analytics, and data science capabilities, including algorithm development, for users of all backgrounds. nSights provides a longitudinal, 360-degree view of each patient by leveraging an ensemble of biomedical information, such as electronic health records, electrocardiograms, radiology images and more. Future iterations will also include digital pathology and genomics. The platform is supported by a flexible data dictionary, allowing for the generation of new patient-level features for analysis. “The potential of electronic health data remains locked at medical centers and is frequently under-leveraged due to data complexity, privacy, and security concerns. Our expanded collaboration with Mayo Clinic Platform provides the framework for nference’s deployment of nSights and enables our customers to access de-identified ‘patient-level’ data to drive research and development of new therapeutics. I look forward to continuing to build and fortify our partnership with the Mayo Clinic team as we work together to improve healthcare through data-derived insights and knowledge.” Mike Koenig, chief commercial officer at nference As a result of the company’s partnerships with major academic medical centers like Mayo Clinic, nSights provides access to the deepest curated patient-level dataset available across all therapeutic areas, including cardiology, oncology, metabolic diseases, immunology, and infectious diseases. The platform offers insights from both structured and unstructured records, representing more than 20 years of longitudinality, including data from over 520 million clinical notes, 1.3 billion lab test results, 10.2 billion flowsheets, and more. “Over the past year, our collaboration with nference, leveraging nSights, has accelerated clinical decision support and care in significant ways," said Maneesh Goyal, chief operating officer, Mayo Clinic Platform. "Data-derived insights and knowledge help us accelerate and enhance innovation and meet the unmet needs of patients everywhere.” About nference Through its powerful technology platform and software, nference is transforming health care by making biomedical knowledge computable. Its partnership with Mayo Clinic has given nference an opportunity to synthesize decades of institutional knowledge, producing real-world evidence in real-time by converting large amounts of de-identified data into deep insights to advance discovery and development of diagnostics and therapeutics. Its proprietary AI-enabled software platform, nSights, has been used to accelerate life sciences research, development, and clinical care in significant ways, including biomarker discovery and validation, real-world evidence generation leveraging real-world data, early disease detection, public health policy generation and validation, and more. nference is headquartered in Cambridge, Mass.

Read More